The FDA has sent McKesson a warning letter for verification requirements violations post DSCA enforcement date.  McKesson reported that the verification requirements at issue include those that apply to wholesale drug distributors when they determine or are notified that a product is suspect or illegitimate. See the link below for the entire warning letter. For more on the Drug Supply Chain Security Act we include a link here.

Source: FDA

Pin It on Pinterest